Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Gen Physiol Biophys ; 25(1): 25-41, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16714773

ABSTRACT

Chronic intermittent high altitude (IHA) hypoxia results in long-term adaptation protecting the heart against acute ischemia/reperfusion injury; however, molecular mechanisms of this phenomenon are not completely elucidated so far. The present study was aimed at investigation of a modulating effect of IHA hypoxia on the expression and/or activation of selected regulatory proteins, with particular emphasis on differential responses in the right ventricle (RV) and left ventricle (LV). Adult male Wistar rats were exposed to IHA hypoxia of 7000 m simulated in a hypobaric chamber (8 h/day, 25 exposures), and protein contents and activities in myocardial fractions were determined by Western blot analysis. In markedly hypertrophic RV of hypoxic rats, gelatinolytic activity of MMP-2 and protein levels of carbonic anhydrase IX (a marker of hypoxia) were significantly enhanced. Study of mitogen-activated protein kinases (MAPKs) revealed no differences in the contents of total p38-MAPK in both ventricles between the IHA and normoxic control rats, whereas activation of p38-MAPK was decreased in the RV and moderately increased in the LV of IHA rats as compared to controls. Extracellular signal regulated kinase-2 (ERK-2) was partially up-regulated in the RV of IHA rats, and, in addition, expression of acidic fibroblast growth factor (aFGF), a potential activator of ERK cascade, was also significantly increased. In contrast, expression of ERKs in the LV as well as their activities in both ventricles, were not affected by IHA hypoxia. Differential effects of IHA hypoxia on c-Jun-N-terminal protein kinases (JNKs) in the RV and LV were also observed. As compared with the controls, total content of JNKs was increased in the RV of the IHA rats, while expression of JNKs in the LV was down-regulated. IHA hypoxia changed neither total levels of Akt kinase in both RV and LV, nor Akt kinase activity in the RV. However, increased levels of activated phospho-Akt kinase were found in the LV of IHA rats. The results demonstrate that adaptation of rat hearts to chronic IHA hypoxia is associated with disctinct changes in the levels and/or activation of several regulatory proteins in two ventricles. The latter could be attributed to both myocardial remodeling and cardioprotection induced by chronic hypoxia.


Subject(s)
Carbonic Anhydrases/metabolism , Heart Ventricles/enzymology , Hypertrophy, Right Ventricular/enzymology , Hypoxia/enzymology , Matrix Metalloproteinase 2/metabolism , Mitogen-Activated Protein Kinases/metabolism , Animals , Blotting, Western , Body Constitution , Chronic Disease , Hematocrit , Hypertrophy, Right Ventricular/etiology , Hypoxia/complications , Male , Mitogen-Activated Protein Kinase 1/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Wistar , Signal Transduction , p38 Mitogen-Activated Protein Kinases/metabolism
2.
Gen Physiol Biophys ; 21(3): 231-55, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12537349

ABSTRACT

Mitogen-activated protein kinases (MAPKs) are evolutionary conserved enzymes connecting cell-surface receptors to critical regulatory targets within cells. The three major MAPK cascades are known, the extracellular signal-regulated protein kinase (ERK) cascade, c-Jun amino-terminal protein kinase/stress-activated protein kinase (JNK/SAPK) cascade and p38-MAPK cascade. This paper is focused on characterization of these MAPK cascades in terms of their distribution and biological role in some pathological processes (apoptosis, hypertrophy) with a special orientation on the role of MAPKs in cardiovascular system during ischemia/reperfusion.


Subject(s)
Homeostasis , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinases/classification , Mitogen-Activated Protein Kinases/metabolism , Myocardial Ischemia/metabolism , Signal Transduction , Animals , Apoptosis , Enzyme Activation , Enzyme Inhibitors , Humans , MAP Kinase Kinase 4 , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinase Kinases/classification , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Multienzyme Complexes/metabolism , Myocardial Reperfusion Injury/metabolism , p38 Mitogen-Activated Protein Kinases
3.
Physiol Res ; 51(6): 565-9, 2002.
Article in English | MEDLINE | ID: mdl-12511179

ABSTRACT

It was previously shown that 4 hours lasting inhibition of nitric oxide synthesis by administration of an L-arginine analogue, the A(G)-nitro-L-arginine methyl ester (L-NAME) changed the affinity of the Na-binding site of Na,K-ATPase thus resulting in elevation of enzyme activity especially at higher concentrations of sodium. Using the same experimental model, we focused our attention in the present study to the question of binding of ATP to the enzyme molecule in the left ventricle (LV), ventricular septum (S) and the right ventricle (RV) of the dog heart. Activation of the enzyme by increasing concentrations of ATP revealed a significant increase of the Vmax only in septum (by 38 %). The K(M) increased significantly in septum (by 40 %) and in left ventricle (by 56 %) indicating an altered sensitivity of the ATP-binding site of Na,K-ATPase in the hearts of NO-deficient animals. The alterations of Na,K-ATPase in its ability to bind and hydrolyze ATP are localized to the tissue surrounding the cavity of the left ventricle.


Subject(s)
Myocardium/enzymology , Nitric Oxide Synthase/deficiency , Sodium-Potassium-Exchanging ATPase/metabolism , Adenosine Triphosphate/metabolism , Animals , Dogs , Enzyme Activation , Enzyme Inhibitors/pharmacology , Heart Ventricles/enzymology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/drug effects
4.
Physiol Res ; 49(1): 65-70, 2000.
Article in English | MEDLINE | ID: mdl-10805406

ABSTRACT

It is known that hypertension is accompanied by increased [Na+]i. The functional properties of Na,K-ATPase, which transports the Na+ out and K+ into myocardial cells during the relaxation phase, were investigated in the left ventricle (LV), septum (SV) and the right ventricle (RV) of anesthetized dogs with moderate acute blood pressure elevation elicited by short-term (4-hour) NO synthase inhibition. The NO-insufficiency was induced by administration of an L-arginine analogue, the N(G)-nitro-L-arginine methyl ester (L-NAME). Concerning the function of Na,K-ATPase under the conditions of lowered NO synthesis, we focused our attention to the binding of Na+ to the enzyme molecule. Activation of the enzyme by increasing Na+ concentrations revealed significant changes in both the maximal velocity (Vmax) and the affinity for Na+ (K(Na)) in all investigated heart sections. The Vmax increased by 27% in LV, by 87% in SV and by 58% in RV. The K(Na) value increased by 86% in LV, by 105% in SV and by 93% in RV, indicating an apparent decrease in the sensitivity of the Na+-binding site in the Na,K-ATPase molecule. This apparently decreased pump affinity for Na+ together with the increase of Vmax suggest that, during the short-term inhibition of NO synthesis, the Na,K-ATPase is capable of extruding the excessive Na+ from the myocardial cells more effectively at higher [Na+]i, as compared to the Na,K-ATPase of control animals.


Subject(s)
Enzyme Inhibitors/pharmacology , Myocardium/enzymology , Nitric Oxide Synthase/antagonists & inhibitors , Sodium-Potassium-Exchanging ATPase/metabolism , Sodium/metabolism , Animals , Dogs , Enzyme Activation/drug effects , Heart Septum/drug effects , Heart Septum/enzymology , Heart Ventricles/drug effects , Heart Ventricles/enzymology , Kinetics , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/metabolism , Sodium/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...